Life Science and Biotech CEO stories

Enjoy this podcast with Leonard Mazur , the co-founder, Chairman, and CEO of Citius Pharmaceuticals , a late-stage biopharma company focused on developing critical care. With over 50 years in the industry, there are many success lessons to be learned as Leonard has co-founded several companies, including Akrimax Pharmaceuticals and Genesis Pharmaceuticals, which he successfully sold to Pierre Fabr...

Today we are honored to have Dr. Josep Bassaganya-Riera, President and CEO of NImmune Biopharma , to talk about how his company is leveraging computational modeling and bioinformatics to develop new therapeutics. Disclaimer The information contained in this website and podcast are purely informational and not considered investment recommendations. Tim Dougherty’s participation in Biotech Insights...

In this podcast, we are pleased to have Mike Walsh, CEO of Patient Advocacy Strategies as our guest. Patient advocacy may seem like a “nice to have” or an afterthought. In this podcast you’ll learn why the opposite is true – that it’s important to glean input from patient groups early on in the lifecycle and throughout the course of developing solutions for patients. Disclaimer   The information c...

It’s shocking that 106,000 people die every year from adverse drug reactions. Moreover, 350,000 people are hospitalized every year, 1.3 million people go to the ER, and it is the fourth leading cause of death in the United States. Adverse drug reactions are a behemoth problem, costing the economy almost half trillion dollars. Disclaimer The information contained in this website and podcast are pur...

In this episode, filed at Science Square in Atlanta, we speak with David Francis and Mighten Yip of Palate Therapeutics , whose mission is to alter people’s food preferences away from sugary foods using therapeutic mouthwash. Disclaimer The information contained in this website and podcast are purely informational and not considered investment recommendations. Tim Dougherty’s participation in Biot...

With over 1.5 million people suffering traumatic brain injuries a year, 80,000 stroke victims, and millions of concussions, the impact that brain impairment has on society is not to be ignored. We spoke with William Korinek of Astrocyte Pharmaceuticals , who is developing neuroprotein therapies for these conditions. Disclaimer The information contained in this website and podcast are purely inform...

There are 1.4 million meniscus procedures performed in the US and Europe every single year. Most of those are meniscetomy which is when the meniscus is removed. The problem is that once it is gone, so is the cushioning that protects the knee joint and cartilage, accelerating arthritis. A quarter of people continue to have pain after a few years. Millions of people have this procedure and it’s not...

Our guest today is Dr. Ivan Liachko, the CEO of Seattle-based Phase Genomics , a company whose core technology is ultra-long range genome sequencing. He’s also the founder of Genome Startup Day , dedicated to helping new biotech entrepreneurs transition from academic settings into industry and entrepreneurship. Disclaimer The information contained in this website and podcast are purely information...

Tune in for this insightful podcast with David Weinstock , the Vice President of Discovery Oncology at Merck, to find out what pharma investors really think when they are interviewing startups looking for funding. Disclaimer The information contained in this website and podcast are purely informational and not considered investment recommendations. Tim Dougherty’s participation in Biotech Insights...

Our guest today is another Atlanta luminary, Dr. Marvin Whiteley , the founder and CSO of SynthBiome , Inc. Deaths are expected to increase over the next 20-30 years due to antibiotic resistant infections.   It’s common for people to go into the hospital for something innocuous, get an infection, and find that the bacterium doesn’t respond to antibiotic. There are strains infecting people outside...

Carter Cliff  is the CEO of Papillon Therapeutics. Papillon is advancing genetic medicines for life threatening conditions including Cystinosis, Friedreich's ataxia, Danon disease, and Alzheimer's disease, and the company is currently partnered with Novartis on a phase 1/2 trial for their lead candidate in cystinosis. Carter has a multi-decade career in biotech and life sciences and is als...

Today we’ve got Dr. Jonathan Arambula and Dr. Krystle Karoscik of InnovoTex, an oncology therapeutics company developing a platform of smart molecules capable of circumventing drug resistance often seen in treating ovarian cancer. They’re doing it in a safer way – hear about all this and more by listening to the show! Disclaimer The information contained in this website and podcast are purely info...

We’re going to talk with  Peter Pitts , President of  Center for Medicine in the Public Interest , about the IRA, which is impacting every company in biotech. The Inflation Reduction Act, or IRA, authorizes the price negotiation for a group of medicines selected by the government and, interestingly, allows no public pronouncements after the fact, by the companies. Disclaimers The information conta...

Today we’re excited to have Subh Roy who will share his insights about how to get funding for your biotech. Disclaimer The information contained in this website and podcast are purely informational and not considered investment recommendations.  Tim Dougherty’s participation in Biotech Insights is separate and apart from his role as an investment advisor representative. Nothing contained herein ma...

Dr. Dennis Liotta  is very humble but don’t let that fool you – underneath the poised demeanor he’s a impassioned drug discovery giant who has made a significant contribution to improving the disease state of the world’s poor. The information contained in this website and podcast are purely informational and not considered investment recommendations.  Tim Dougherty’s participation in Biotech Insig...

Today we have four very special guests, some friends of mine, who are going to share with us the story behind all the momentum driving life sciences in Atlanta. · Eddie Lai represents the MetroAtlanta Chamber of Commerce · Courtney Law represents a group called Biolocity, which bridges Emory and Georgia Tech · Ryan Lawler is from Biosparks Labs, funded by Georgia Technology Ventures, supporting th...

Our guest today is Gaurav Byagathvalli , a Geoge Tech alum and the CEO of Piezo Therapeurtics , a company developing an innovative nucleic acid delivery platform for DNA and mRNA vaccines. Instead of using complicated equipment they use simplified circuits, analogous to what is in a lighter, to product the same impulse. They then use microneedles, which function as electrodes, to conduct those pul...

Our guest today is Nolan Townsend, the CEO of LEXEO Therapeutics, which focused on expanding the application of crisper gene therapies past rare diseases where they’ve generally been applied to more prevalent kinds of diseases. What got me excited for the talk was the enthusiasm that Nolan expressed for the application of genetic therapies to more common diseases, which is where all the costs live...

Today I am really excited to have Charles Gellman , CEO of HiDO Health . HiDO is a company that is focused on using artificial intelligence to help patients manage their medications for chronic disease. Each year, almost 250,000 in America die as a result of medical errors associated with lack of adherence to a prescription schedule, making it the third largest cause of death in the US. Disclaimer...

Our guest today is Dr. Amy Baxter, the CEO of Pain Care Labs , a company dedicated to using mechanical platforms such as vibrating devices to alleviate fear and pain associated with needles as well as reducing muscular skeletal pain in adults.   Disclaimer The information contained in this website and podcast are purely informational and not considered investment recommendations.  Tim Dougherty’s...

Today we are joined by Charles DeCoster , CEO, and Tony Watson , COO, of Xenocor , a company that is revolutionizing laparoscopic surgery with a new scope they call Saberscope. This device was designed to be less expensive, more effective at providing the surgeon with available light, and safer for the patient.   Laparoscopic surgery was invented in the 1980’s and the technology platform is now 30...

This episode we’re doing something different. We’re visiting some of the most compelling stories and CEOs of our earlier editions, to update their journeys. I wanted to do this for two reasons. ·       The people in this industry are some of the grittiest, most determined, and most philanthropic, in terms of their commitment to their science and patients, people that I have ever known. ·       By...

Recently on the Biotech and Life Science CEO’s podcast, we’ve been talking about the speed at which change is occurring in the life sciences. And nowhere is that clearer than in the field of mRNA. By now everyone must know that the COVID vaccines were created literally days after the genome of the virus had been sequenced. But I don’t think we’ve still processed what that really means. Our guest t...

In this podcast, we are joined by historian Dr. Nicolas Hoffmann who recounts a slew of quirky Civil War medicine stories that will have you rolling in laughter. Let’s go! Over the last few months of this podcast, we’ve had the opportunity to learn about tiny pill-sized endoscopes that can be swallowed and controlled on their path through the digestive tract by the healthcare provider. We’ve heard...

Today we are going to discuss advancements in improving the efficiency of those clinical trials. Our guest is Ian Strug who is the co-founder and Chief Revenue Officer at Virgo Surgical Video Solutions . Virgo provides cloud video capture, management, and artificial intelligence analysis for endoscopic medicine. Disclaimer The information contained in this website and podcast are purely informatio...